FDA Issues Final Industry Guidance for Developing Antiretroviral Drugs for HIV Treatment


This week, FDA announced the availability of a final guidance [PDF 610 KB] for industry entitled “Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment.” The guidance provides recommendations for the development of antiretroviral drugs regulated within the FDA Center for Drug Evaluation and Research for the treatment of HIV infection. This guidance assists sponsors in…

FDA approves new treatment for HIV


The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. The CDC estimates that 1.2 million persons ages 13 years and older are living…

New Coating for HIV Drug Holds Promise for Patients

VOA blog - pill image

Managing HIV could get a lot easier with a new delivery system for anti-AIDS drugs. Instead of daily pills, the treatment could lead to drugs that can be administered just once or twice per year. The new delivery system, designed at the University of Nebraska Medical Center, starts with protease inhibitors, the antiretroviral drugs commonly…

HHS & NIH Seek Public Comments on LGBT Health

HHS Logo

There are two opportunities to offer public comment on plans to better understand and improve the health and wellness of lesbian, gay, bisexual and transgender (LGBT) Americans. These federal plans include but extend beyond HIV, addressing many other health concerns of the LGBT community. NIH LGBT Research Strategic Plan The National Institutes of Health (NIH)…

Spotlight on the Updated National HIV/AIDS Strategy at USCA 2015


The National HIV/AIDS Strategy: Updated to 2020 was in the spotlight during a plenary session of the 2015 U.S. Conference on AIDS in Washington, DC, yesterday (September 10, 2015). The annual conference, sponsored by the National Minority AIDS Council , has assembled nearly 3,000 participants from across the country in Washington, DC. ONAP Director Brooks Issues…

AIDSinfo Releases New Edition of HIV/AIDS Glossary Featuring the Addition of Images


AIDSinfo, a service of the U.S. Department of Health and Human Services, offers access to many Federal HIV-related resources, including the AIDSinfo Glossary of HIV/AIDS-Related Terms, a guide to help people understand the complex terminology of HIV/AIDS. The glossary includes definitions in English and Spanish for more than 700 HIV/AIDS-related terms. The latest edition of…

Be a Part of the NIH Digital Summit on October 19th


Have you heard? You can join the National Institutes of Health (NIH) Digital Summit on October 19th. The free, day-long event will highlight “how digital is being used by government agencies, clinicians, [caregivers], scientists, patients, and the public to communicate information on health and science.”   Digital tools and technology are changing rapidly. At, we…

Statement on NIH Efforts to Focus Research to End the AIDS Pandemic

NIH logo

Extraordinary progress has been made in HIV/AIDS research over the last 34 years, transforming what was once a terrifying and almost inevitably fatal disease into a treatable disorder. People with HIV/AIDS can now experience an almost normal life expectancy if antiretrovirals are started promptly and continued for life. But the disease remains a significant public…